Gilbert & Cook, Inc. Horizon Therapeutics Public LTD CO Transaction History

Gilbert & Cook, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$79.4 - $116.36 $98,217 - $143,937	-1,237 Reduced 27.61%	3,243 $259,000
Q1 2022 May 02, 2022	BUY	$86.42 - $109.81 $18,839 - $23,938	218 Added 5.11%	4,480 $471,000
Q4 2021 Jan 19, 2022	BUY	$98.56 - $119.91 $6,603 - $8,033	67 Added 1.6%	4,262 $459,000
Q3 2021 Oct 13, 2021	BUY	$91.91 - $110.37 $13,143 - $15,782	143 Added 3.53%	4,195 $460,000
Q2 2021 Jul 13, 2021	BUY	$86.24 - $95.92 $61,575 - $68,486	714 Added 21.39%	4,052 $379,000
Q1 2021 Apr 14, 2021	BUY	$71.83 - $95.48 $239,768 - $318,712	3,338 New	3,338 $307,000
Q4 2020 Feb 11, 2021	SELL	$67.0 - $84.39 $215,874 - $271,904	-3,222 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $177,951 - $257,534	3,222 New	3,222 $223,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Gilbert & Cook, Inc., based on Form 13F filings with the SEC.

Stay updated on Gilbert & Cook, Inc. with notifications on news.